Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Oct 22, 2018 7:48pm

92 Views

Post# 28852256

RE:RE:RE:Consequences

Your first post was around the time the RBC report was released.

You’re clearly on the short side.

That’s fine if you’re honest about it instead of creating FUD. Bulls & Bears make money.

The latter types of posts lead to your 113 ignores.

That’s an impressive number....you have a strong work ethic :)

bfw

PinnacleX wrote: No this does NOT happen all the time. You say your a former fund mangaer and you say that a small cap bio that went profitable and BEAT on earnings for the first time in its history drops this much? get real. Ive been in 150 biotechs this size and not once have I see this happen after a quarter like that. Please enlighten me with the stocks you seen this happen to that are in THs market cap.

Where this stops is anyones guess.

Bullboard Posts

How one company is disrupting PoC testing